MX2019000977A - Composiciones farmacéuticas a base de curcumina y procedimientos para su fabricación. - Google Patents
Composiciones farmacéuticas a base de curcumina y procedimientos para su fabricación.Info
- Publication number
- MX2019000977A MX2019000977A MX2019000977A MX2019000977A MX2019000977A MX 2019000977 A MX2019000977 A MX 2019000977A MX 2019000977 A MX2019000977 A MX 2019000977A MX 2019000977 A MX2019000977 A MX 2019000977A MX 2019000977 A MX2019000977 A MX 2019000977A
- Authority
- MX
- Mexico
- Prior art keywords
- curcumin
- fabricating
- methods
- pharmaceutical compositions
- based pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describen composiciones farmacéuticas, las composiciones consisten esencialmente en emulsiones acuosas de una cantidad terapéuticamente eficaz de un compuesto diarilheptanoide (tal como curcumina). También se describen procedimientos para fabricar las composiciones y para usarlas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662366807P | 2016-07-26 | 2016-07-26 | |
PCT/US2017/042818 WO2018022378A1 (en) | 2016-07-26 | 2017-07-19 | Curcumin-based pharmaceutical compositions and methods for fabricating thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019000977A true MX2019000977A (es) | 2019-08-01 |
Family
ID=61012353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019000977A MX2019000977A (es) | 2016-07-26 | 2017-07-19 | Composiciones farmacéuticas a base de curcumina y procedimientos para su fabricación. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20180028470A1 (es) |
EP (1) | EP3490578A4 (es) |
JP (1) | JP2019523264A (es) |
KR (1) | KR20190032494A (es) |
AU (1) | AU2017301645A1 (es) |
CA (1) | CA3032149A1 (es) |
MX (1) | MX2019000977A (es) |
WO (1) | WO2018022378A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3946407A4 (en) * | 2019-03-24 | 2022-12-28 | Patel, Naishadhkumar Ramubhai | FORMULATION TO INCREASE THE BIOAVAILABILITY AND STABILITY OF CURCUMINOIDS AND/OR THEIR DERIVATIVES THEREOF |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7968115B2 (en) * | 2004-03-05 | 2011-06-28 | Board Of Regents, The University Of Texas System | Liposomal curcumin for treatment of cancer |
CN100486567C (zh) * | 2004-08-12 | 2009-05-13 | 山东绿叶天然药物研究开发有限公司 | 姜黄素乳剂及其制备方法 |
CN1895239B (zh) * | 2006-06-20 | 2010-05-12 | 中国人民解放军第二军医大学 | 一种姜黄素制剂及其制备方法 |
CN101147727A (zh) * | 2006-09-19 | 2008-03-26 | 大百汇生物科技(深圳)有限公司 | 莪术醇亚微乳及其制备方法和制剂 |
US8383865B2 (en) * | 2007-04-17 | 2013-02-26 | Codman & Shurtleff, Inc. | Curcumin derivatives |
WO2014025672A1 (en) * | 2012-08-04 | 2014-02-13 | Eric Hauser Kuhrts | Water-soluble lipophilic natural compound formulations |
-
2017
- 2017-07-19 JP JP2019503916A patent/JP2019523264A/ja active Pending
- 2017-07-19 WO PCT/US2017/042818 patent/WO2018022378A1/en unknown
- 2017-07-19 MX MX2019000977A patent/MX2019000977A/es unknown
- 2017-07-19 AU AU2017301645A patent/AU2017301645A1/en not_active Abandoned
- 2017-07-19 US US15/653,769 patent/US20180028470A1/en not_active Abandoned
- 2017-07-19 EP EP17834993.2A patent/EP3490578A4/en not_active Withdrawn
- 2017-07-19 KR KR1020197005188A patent/KR20190032494A/ko not_active Application Discontinuation
- 2017-07-19 CA CA3032149A patent/CA3032149A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20190032494A (ko) | 2019-03-27 |
EP3490578A1 (en) | 2019-06-05 |
WO2018022378A1 (en) | 2018-02-01 |
AU2017301645A1 (en) | 2019-02-07 |
US20180028470A1 (en) | 2018-02-01 |
EP3490578A4 (en) | 2020-02-26 |
CA3032149A1 (en) | 2018-02-01 |
JP2019523264A (ja) | 2019-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202105850YA (en) | Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof | |
EP3481402A4 (en) | CONNECTIONS, COMPOSITIONS AND METHODS FOR TREATING A DISEASE | |
EP3436482A4 (en) | ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND METHODS | |
MY191581A (en) | Anti-pd-1 antibodies | |
EP3484504A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT OF DISEASE | |
EP3615659A4 (en) | COMPOSITIONS AND METHODS OF ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS | |
EP3675859A4 (en) | COMPOUNDS, COMPOSITIONS AND PROCEDURES FOR TREATMENT OF DISEASES | |
EP3641771A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
PH12019501872A1 (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
MX2018008424A (es) | Compuestos antiproliferativos y sus composiciones farmaceuticas y usos. | |
MX2020002123A (es) | Sales de ribociclib y formas en estado sólido de las mismas. | |
AU2018302170A1 (en) | Pharmaceutical compositions comprising entrectinib | |
EP3670511A4 (en) | TETRAHYDROPROTOBERBERIN COMPOUND, METHOD OF MANUFACTURING AND USING IT, AND PHARMACEUTICAL COMPOSITION | |
EP3409709A4 (en) | PHOTO-PROCESSING, COMPOUND AND COMPOSITION USED THEREOF | |
EP3647313A4 (en) | SUBSTITUTED ARYLETHER COMPOUND, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION AND USE | |
EP3497077A4 (en) | AMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS OF USE | |
IN2014CH00840A (es) | ||
EP3539978A4 (en) | NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION WITH IT AS THE ACTIVE INGREDIENT | |
EA201791716A1 (ru) | Фармацевтический состав | |
PH12017502148A1 (en) | Pharmaceutical compositions and use thereof | |
EP3284743A4 (en) | Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof | |
EP3641797A4 (en) | PROCESS FOR THE PREPARATION OF A STANDARDIZED COMPOSITION OF ARJUNOGLUCOSIDE FROM THE BARK DETERMINALIA ARJUNA | |
EP3496714A4 (en) | DRUG COMPOSITIONS. | |
EP3881841A4 (en) | PHARMACEUTICAL COMPOSITION | |
WO2016069542A3 (en) | Lactone compounds and methods of making and using same |